High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study

BACKGROUND: One third of coronavirus disease 2019 (COVID-19) patients have gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA has been detected in stool samples of approximately 50% of COVID-19 individuals. Fecal calprotectin is a marker of gastrointestinal i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zerbato, Verena, Di Bella, Stefano, Giuffrè, Mauro, Jaracz, Anna Wladyslawa, Gobbo, Ylenia, Luppino, Diego, Macor, Paolo, Segat, Ludovica, Koncan, Raffaella, D'Agaro, Pierlanfranco, Valentini, Michael, Crocé, Lory Saveria, Ruscio, Maurizio, Luzzati, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Prospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192288/
https://www.ncbi.nlm.nih.gov/pubmed/34168414
http://dx.doi.org/10.3748/wjg.v27.i22.3130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192288/
https://www.ncbi.nlm.nih.gov/pubmed/34168414
http://dx.doi.org/10.3748/wjg.v27.i22.3130

Ejemplares similares